Sponsor:
University of Washington
Code:
NCT07699380
Conditions
Type 1 Diabetes (T1D)
Metabolic Diseases
Glucose Metabolism Disorders
Endocrine System Diseases
Autoimmune Diseases
Eligibility Criteria
Sex: All
Age: 18 - 69
Healthy Volunteers: Not accepted
Interventions
AMX0035
Placebo
Brief summary:
Conditions
Type 1 Diabetes (T1D)
Metabolic Diseases
Glucose Metabolism Disorders
Endocrine System Diseases
Autoimmune Diseases
Study ID
NCT07699380
Start date
Jun, 2026
Status verified date
May, 2026
Completion date
Dec, 2029
Anticipated
Primary completion date
Dec, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 69
Healthy Volunteers: Not accepted
Enrollment
60 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: AMX0035
placebo comparator: Placebo
Interventions
AMX0035
Placebo
Primary outcome measure
Central contacts
Locations
University of Washington Medicine Diabetes Institute (UWMDI)
Recruiting
Seattle, Washington, United States, 98109
Contacts
Principal Investigator:
Petter Bjornstad, MD
Sponsor
University of Washington
Last update posted
Jul 13, 2026
Last verified
May, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Washington on 2026-07-13.